Get my own profile
Public access
View all6 articles
0 articles
available
not available
Based on funding mandates
Co-authors
- Abraham StroockProfessor of Chemical and Biomolecular Engineering, Cornell UniversityVerified email at cornell.edu
- Claudia FischbachProfessor, Meinig School of Biomedical Engineering, Director Physical Sciences Oncology CenterVerified email at cornell.edu
- Ying ZhengDepartment of Bioengineering, University of WashingtonVerified email at uw.edu
- Nakwon ChoiPrincipal Researcher, Brain Science Institute, Korea Institute of Science and TechnologyVerified email at kist.re.kr
- Michael KotlikoffCornell UniversityVerified email at cornell.edu
- Ashley WoodsVerified email at cornell.edu
- Gerard SergeantVerified email at dkit.ie
- Mark HollywoodDundalk Institute of TechnologyVerified email at dkit.ie
- Scott S VerbridgeProgram Director, NIH/NIDCRVerified email at nih.gov
- Michele SteffeyProfessor of Small Animal Soft Tissue Surgery, University of California-DavisVerified email at ucdavis.edu
- Bob DoranUniversity of South CarolinaVerified email at sc.edu
- Nathaniel C. CadyEmpire Innovation Professor, SUNY Polytechnic InstituteVerified email at sunypoly.edu
Follow
Michael Craven, Ph.D.
3D Bio Therapeutics, Hollister Incorporated, iFyber, Cornell University
Verified email at cornell.edu - Homepage